The mood is jittery ahead of the September series derivative expiry on Thursday and the Reserve Bank of India’s policy meeting on Friday when the central bank is expected to raise rates. But, analysts do not rule out a technical rebound around 17,000-17,150.
5 pharma stks with upside potential of up to 12%
Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to